Focus Stocks
Visa Closing in to Resistance
Published on Wednesday, 08 February 2012 07:24 Written by TradersHuddle Wire
New York, February 8th (TradersHuddle.com) - Shares of Visa Inc. (NYSE:V) are trading very close to calculated resistance at $108.27 with the current price action closing at just $106.98 placing the stock near levels that make it difficult to buy.
Visa Inc. (NYSE:V) is a retail electronic payments network operator. The company manages global financial services and offers global commerce through the transfer of value and information among financial institutions, merchants, consumers, businesses and government entities.
Visa's current stock range is defined by current calculated support defined at $98.80 and by the resistance level at $108.27, the stock is clearly over-extended from support, making it difficult to establishing new long positions at this level.
Traders don't have a clear entry point for Visa, as the stock is well above support, however, as the stock pulls back towards $98.80 it will definitely provide a reference point to establish a trade. On the other hand if the stock decides to break above resistance level at $108.27 then traders will get an opportunity to enter Visa stock by establishing a position as the stock moves to a higher range.
Related Articles
- Visa Is Approaching its 50 Day Moving Average
- Is Visa Close to Support?
- Visa and Obopay Collaborate for Near Real-Time Electronic Disbursements to Visa Prepaid Cards
- Trading the Setup In Visa
- Visa Debit Takes Flight with Air Canada
- Samsung and Visa Showcase Mobile Payments at the London 2012 Olympic and Paralympic Games
- Is Visa Closing in to Support?
- Visa Raises "No Signature" Limit to $50 to Increase Merchant Efficiency & Consumer Convenience
- Visa Rallies Fans to Join Worldwide Cheer with Launch of Global Olympic Games-Themed Marketing Campaign – Go World
- Visa Inc. Announces Participation in Four Investor Conferences in May
Related Partner Headlines
- Visa Inc. (V): Today's Featured Diversified Services Winner - TheStreet.com
- Suspicious Action in Some Big Names - TheStreet.com
- Visa Stock To Go Ex-dividend Tomorrow (V) - TheStreet.com
- Visa Inc. (V): Today's Featured Diversified Services Loser - TheStreet.com
- Visa Inc. (V): Today's Featured Diversified Services Winner - TheStreet.com
- For Analysis of Visa, Big Media: 2, Blogs: 0 - TheStreet.com
- UPDATE: Stifel Nicolaus Raises PT to $131 on Visa; Prepared for NT Headwinds - Benzinga
- UPDATE: Deutsche Bank Raises PT to $125 on Visa; Strong Q2 - Benzinga
- UPDATE: Guggenheim Raises Visa's PT - Benzinga
- Visa Easily Beats Wall Street's Profit View - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Coming Week: Top Nine Earnings on Deck - TheStreet.com -
Something's Not Right in the Video-Game Space - TheStreet.com -
For Ambitious Students, Entrepreneurship Can Be a Big Win - TheStreet.com -
Stock Futures Rise on Eurobond Talk - TheStreet.com -
You Can Let Your Guard Down: Ask Noah - TheStreet.com -
Apple Strengthens Its Supply Chain - TheStreet.com -
NYSE Is Winning the IPO Listing War - TheStreet.com -
Toyota Is Back as May Sales Continue Auto Industry Recovery - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,529.75 Trade time:4:05PM EDT Value change:▲33.60 (0.27%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,320.68 Trade time:4:32PM EDT Value change:▲1.82 (0.14%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,839.38 Trade time:5:16PM EDT Value change:▼10.74 (-0.38%)In The Wires
-
Vertex Receives European CHMP Positive Opinion for KALYDECO™ (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis -
SunOpta Enters Into Agreement to Divest Its Canadian Based Natural Health Products Business -
PC Connection, Inc. (PCCC) To Present at The SeeThruEquity First Annual Small Cap Investor Conference on Tuesday, June 5, 2012 -
Aeroflex Announces Amendment to Credit Agreement -
Alliance Data to Participate at Upcoming Investor Conferences -
PCA3 Test Featured at American Urological Association Meeting -
MOCON Announces Quarterly Dividend -
Government of Rwanda Introduces Merck's ROTATEQ® (Rotavirus Vaccine, Live, Oral, Pentavalent) to Help Protect Children Against Rotavirus









